+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Virus Drug"

Global Human Immunodeficiency Virus Therapeutics Market by Drug Class (Coreceptor Antagonists, Entry & Fusion Inhibitors, Integrase Inhibitors), End-User (Hospitals & Clinics, Specialty Centers), Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Human Immunodeficiency Virus Therapeutics Market by Drug Class (Coreceptor Antagonists, Entry & Fusion Inhibitors, Integrase Inhibitors), End-User (Hospitals & Clinics, Specialty Centers), Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 194 Pages
  • Global
From
Human Immunodeficiency Virus Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class (Entry & Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Human Immunodeficiency Virus Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Drug Class (Entry & Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • October 2023
  • 75 Pages
  • Global
From
Epstein Barr virus (EBV) - Pipeline Insight, 2024 - Product Thumbnail Image

Epstein Barr virus (EBV) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Respiratory syncytial virus (RSV) - Pipeline Insight, 2024 - Product Thumbnail Image

Respiratory syncytial virus (RSV) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
relapsed/refractory (R/R) Epstein-Barr virus (EBV) - Pipeline Insight, 2024 - Product Thumbnail Image

relapsed/refractory (R/R) Epstein-Barr virus (EBV) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutics Global Market Report 2024 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutics: Global Strategic Business Report - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics: Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
Herpes Simplex Virus Treatment Market by Type, Drug type, Distribution channel, and Geography: Forecast up to 2027 - Product Thumbnail Image

Herpes Simplex Virus Treatment Market by Type, Drug type, Distribution channel, and Geography: Forecast up to 2027

  • Report
  • July 2023
  • 321 Pages
  • Global
From
Epstein Barr virus (EBV) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Epstein Barr virus (EBV) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Herpes Zoster Infection Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Herpes Zoster Infection Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 116 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 82 Pages
  • Global
From
Rabies Virus - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rabies Virus - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Hepatitis C Virus (HCV) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatitis C Virus (HCV) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
relapsed/refractory Epstein-Barr virus (EBV) - Epidemiology Forecast to 2032 - Product Thumbnail Image

relapsed/refractory Epstein-Barr virus (EBV) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Hepatitis B Virus (CHB) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Hepatitis B Virus (CHB) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Respiratory Tract Infection Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Respiratory Tract Infection Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Market Spotlight: Zika virus - Product Thumbnail Image

Market Spotlight: Zika virus

  • Report
  • February 2021
  • 24 Pages
  • Global
Global Zika Virus Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Zika Virus Therapeutics Market 2022-2026

  • Report
  • May 2022
  • Global
From
Global Zika Virus Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Zika Virus Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Human Immunodeficiency Virus (HIV) Therapeutics - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Therapeutics - Global Drug Forecast and Market Analysis to 2029

  • Report
  • February 2021
  • 254 Pages
  • Global
From
Loading Indicator

The Virus Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat viral infections. These drugs are designed to target specific viruses, such as HIV, hepatitis, and influenza, and can be used to treat both acute and chronic infections. They can also be used to prevent the spread of viruses, such as through vaccinations. The Virus Drug market is highly competitive, with many companies vying for market share. Companies in the market include Gilead Sciences, Merck & Co., Pfizer, GlaxoSmithKline, Johnson & Johnson, Bristol-Myers Squibb, and Novartis. These companies are engaged in research and development of new drugs, as well as the marketing and sale of existing drugs. Show Less Read more